Ulcerative colitis is a form of inflammatory bowel disease (IBD). The condition affects the colon by causing inflammation there but also has an impact on other parts of the body. Ulcerative colitis ...
MK-6194 is under clinical development by Merck and currently in Phase II for Ulcerative Colitis. According to GlobalData, Phase II drugs for Ulcerative Colitis have a 45% phase transition success rate ...
Indeterminate colitis (IC) is a diagnosis used to describe inflammatory bowel disease (IBD) when a person has features of IBD, but it's not yet understood whether they have ulcerative colitis or Crohn ...
Up to 25,000 people with ulcerative colitis (UC) in England could be in line for treatment with Pfizer’s once-daily oral therapy Velsipity, after NICE recommended its use by the NHS. The new ...
Ulcerative proctitis can be extremely challenging to manage. The use of oral medications can frequently be associated with systemic side effects, while the use of topical agents are rarely ...
This therapy is the first to activate specific components of the ... Study Traces Ebola's Route to the Skin Surface Jan. 1, 2025 — Researchers have traced a cellular route Ebola virus (EBOV ...